Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 22

1.

Response to chemotherapy in patients with recurrent rectal cancer in previously irradiated area.

Alberda WJ, Haberkorn BC, Morshuis WG, Oudendijk JF, Nuyttens JJ, Burger JW, Verhoef C, van Meerten E.

Int J Colorectal Dis. 2015 Aug;30(8):1075-80. doi: 10.1007/s00384-015-2270-2. Epub 2015 Jun 17.

2.

The use of neo-adjuvant chemotherapy in patients with resectable colorectal liver metastases: Clinical risk score as possible discriminator.

Ayez N, van der Stok EP, Grünhagen DJ, Rothbarth J, van Meerten E, Eggermont AM, Verhoef C.

Eur J Surg Oncol. 2015 Jul;41(7):859-67. doi: 10.1016/j.ejso.2015.04.012. Epub 2015 May 2.

PMID:
25979624
3.

Neo-adjuvant chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastases: the CHARISMA randomized multicenter clinical trial.

Ayez N, van der Stok EP, de Wilt H, Radema SA, van Hillegersberg R, Roumen RM, Vreugdenhil G, Tanis PJ, Punt CJ, Dejong CH, Jansen RL, Verheul HM, de Jong KP, Hospers GA, Klaase JM, Legdeur MC, van Meerten E, Eskens FA, van der Meer N, van der Holt B, Verhoef C, Grünhagen DJ.

BMC Cancer. 2015 Mar 26;15:180. doi: 10.1186/s12885-015-1199-8.

4.

Chemoradiation therapy for rectal cancer in the distal rectum followed by organ-sparing transanal endoscopic microsurgery (CARTS study).

Verseveld M, de Graaf EJ, Verhoef C, van Meerten E, Punt CJ, de Hingh IH, Nagtegaal ID, Nuyttens JJ, Marijnen CA, de Wilt JH; CARTS Study Group.

Br J Surg. 2015 Jun;102(7):853-60. doi: 10.1002/bjs.9809. Epub 2015 Apr 2.

PMID:
25847025
5.

Digital acrometastasis.

Sandberg Y, van de Wiel BA, van Meerten E.

Arthritis Rheumatol. 2015 May;67(5):1410. doi: 10.1002/art.39053. No abstract available.

PMID:
25808145
6.

Phase I study of cisplatin, hyperthermia, and lapatinib in patients with recurrent carcinoma of the uterine cervix in a previously irradiated area.

van Meerten E, Franckena M, Wiemer E, van Doorn L, Kraan J, Westermann A, Sleijfer S.

Oncologist. 2015 Mar;20(3):241-2. doi: 10.1634/theoncologist.2014-0365. Epub 2015 Feb 6.

7.

Intraoperative radiation therapy reduces local recurrence rates in patients with microscopically involved circumferential resection margins after resection of locally advanced rectal cancer.

Alberda WJ, Verhoef C, Nuyttens JJ, van Meerten E, Rothbarth J, de Wilt JH, Burger JW.

Int J Radiat Oncol Biol Phys. 2014 Apr 1;88(5):1032-40. doi: 10.1016/j.ijrobp.2014.01.014.

PMID:
24661656
8.

Outcome in patients with resectable locally recurrent rectal cancer after total mesorectal excision with and without previous neoadjuvant radiotherapy for the primary rectal tumor.

Alberda WJ, Verhoef C, Nuyttens JJ, Rothbarth J, van Meerten E, de Wilt JH, Burger JW.

Ann Surg Oncol. 2014 Feb;21(2):520-6. doi: 10.1245/s10434-013-3306-x. Epub 2013 Oct 12.

PMID:
24121879
9.

The CARTS study: Chemoradiation therapy for rectal cancer in the distal rectum followed by organ-sparing transanal endoscopic microsurgery.

Bökkerink GM, de Graaf EJ, Punt CJ, Nagtegaal ID, Rütten H, Nuyttens JJ, van Meerten E, Doornebosch PG, Tanis PJ, Derksen EJ, Dwarkasing RS, Marijnen CA, Cats A, Tollenaar RA, de Hingh IH, Rutten HJ, van der Schelling GP, Ten Tije AJ, Leijtens JW, Lammering G, Beets GL, Aufenacker TJ, Pronk A, Manusama ER, Hoff C, Bremers AJ, Verhoef C, de Wilt JH.

BMC Surg. 2011 Dec 15;11:34. doi: 10.1186/1471-2482-11-34.

10.

Chemoradiation for advanced hypopharyngeal carcinoma: a retrospective study on efficacy, morbidity and quality of life.

Keereweer S, Kerrebijn JD, Al-Mamgani A, Sewnaik A, Baatenburg de Jong RJ, van Meerten E.

Eur Arch Otorhinolaryngol. 2012 Mar;269(3):939-46. doi: 10.1007/s00405-011-1694-8. Epub 2011 Jul 8.

11.

Effect of omeprazole on the pharmacokinetics and toxicities of irinotecan in cancer patients: a prospective cross-over drug-drug interaction study.

van der Bol JM, Loos WJ, de Jong FA, van Meerten E, Konings IR, Lam MH, de Bruijn P, Wiemer EA, Verweij J, Mathijssen RH.

Eur J Cancer. 2011 Apr;47(6):831-8. doi: 10.1016/j.ejca.2010.11.030. Epub 2011 Jan 6.

12.

Combined therapy for thyroid squamous cell carcinoma.

De Vos FY, Sewnaik A, de Wilt JH, Smid EJ, den Bakker MA, van Meerten E.

Head Neck. 2012 Jan;34(1):131-4. doi: 10.1002/hed.21484. Epub 2010 Jul 22.

PMID:
20652981
13.

Pathological analysis after neoadjuvant chemoradiotherapy for esophageal carcinoma: the Rotterdam experience.

van Meerten E, van der Gaast A, Tilanus HW, Poley JW, Muller K, van Dekken H.

J Surg Oncol. 2009 Jul 1;100(1):32-7. doi: 10.1002/jso.21295.

PMID:
19402081
14.

[Chemotherapy during clozapine treatment. Increased risk of agranulocytosis?].

van Gool AR, van der Velden MT, Oosten AW, van Meerten E, Verhoeven WM, Loonen AJ.

Tijdschr Psychiatr. 2008;50(10):673-8. Dutch.

15.

Quality of life during neoadjuvant treatment and after surgery for resectable esophageal carcinoma.

van Meerten E, van der Gaast A, Looman CW, Tilanus HW, Muller K, Essink-Bot ML.

Int J Radiat Oncol Biol Phys. 2008 May 1;71(1):160-6. doi: 10.1016/j.ijrobp.2007.09.038. Epub 2007 Dec 31.

PMID:
18164846
16.

First-line treatment with oxaliplatin and capecitabine in patients with advanced or metastatic oesophageal cancer: a phase II study.

van Meerten E, Eskens FA, van Gameren EC, Doorn L, van der Gaast A.

Br J Cancer. 2007 May 7;96(9):1348-52. Epub 2007 Apr 17.

17.

Neoadjuvant concurrent chemoradiation with weekly paclitaxel and carboplatin for patients with oesophageal cancer: a phase II study.

van Meerten E, Muller K, Tilanus HW, Siersema PD, Eijkenboom WM, van Dekken H, Tran TC, van der Gaast A.

Br J Cancer. 2006 May 22;94(10):1389-94.

18.

Systemic treatment for oesophageal cancer.

van Meerten E, van der Gaast A.

Eur J Cancer. 2005 Mar;41(5):664-72. Epub 2005 Jan 8. Review.

PMID:
15763640
19.

[Clinical thinking and decision making in practice. A young woman with fever, arthralgia and exanthema].

van Meerten E, Berghout A, Hendriks WD, Swaak AJ.

Ned Tijdschr Geneeskd. 2002 Jun 15;146(24):1121-5. Dutch.

PMID:
12092302
20.

Development of an interphase fluorescent in situ hybridization (FISH) test to detect t(8;21) in AML patients.

Hagemeijer A, de Klein A, Wijsman J, van Meerten E, de Greef GE, Sacchi N.

Leukemia. 1998 Jan;12(1):96-101.

PMID:
9436927
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk